AARTI DRUGS
|
AARTI DRUGS Last 5 Year Income Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Gross Sales | ₹2,565 Cr | ₹2,387 Cr | ₹2,529 Cr | ₹2,716 Cr | ₹2,489 Cr |
| Sales | ₹2,521 Cr | ₹2,369 Cr | ₹2,509 Cr | ₹2,706 Cr | ₹2,489 Cr |
| Job Work/ Contract Receipts | - | - | - | - | - |
| Processing Charges / Service Income | - | - | - | - | - |
| Revenue from property development | - | - | - | - | - |
| Other Operational Income | ₹44 Cr | ₹18 Cr | ₹20 Cr | ₹10 Cr | - |
| Less: Excise Duty | - | - | - | - | - |
| Net Sales | ₹2,565 Cr | ₹2,387 Cr | ₹2,529 Cr | ₹2,716 Cr | ₹2,489 Cr |
| EXPENDITURE : | |||||
| Increase/Decrease in Stock | ₹-0.37 Cr | ₹19 Cr | ₹26 Cr | ₹-1.76 Cr | ₹-86 Cr |
| Raw Material Consumed | ₹1,544 Cr | ₹1,447 Cr | ₹1,580 Cr | ₹1,815 Cr | ₹1,701 Cr |
| Opening Raw Materials | ₹177 Cr | ₹183 Cr | ₹197 Cr | ₹222 Cr | ₹199 Cr |
| Purchases Raw Materials | ₹1,439 Cr | ₹1,357 Cr | ₹1,486 Cr | ₹1,669 Cr | ₹1,614 Cr |
| Closing Raw Materials | ₹188 Cr | ₹177 Cr | ₹183 Cr | ₹197 Cr | ₹222 Cr |
| Other Direct Purchases / Brought in cost | ₹115 Cr | ₹84 Cr | ₹80 Cr | ₹121 Cr | ₹109 Cr |
| Other raw material cost | - | - | - | - | - |
| Power & Fuel Cost | ₹175 Cr | ₹156 Cr | ₹154 Cr | ₹156 Cr | ₹128 Cr |
| Electricity & Power | ₹172 Cr | ₹154 Cr | ₹151 Cr | ₹153 Cr | ₹126 Cr |
| Oil, Fuel & Natural gas | - | - | - | - | - |
| Coals etc | - | - | - | - | - |
| Other power & fuel | ₹3.44 Cr | ₹2.93 Cr | ₹3.46 Cr | ₹3.12 Cr | ₹2.62 Cr |
| Employee Cost | ₹116 Cr | ₹99 Cr | ₹91 Cr | ₹80 Cr | ₹69 Cr |
| Salaries, Wages & Bonus | ₹112 Cr | ₹95 Cr | ₹87 Cr | ₹77 Cr | ₹66 Cr |
| Contributions to EPF & Pension Funds | ₹3.08 Cr | ₹2.63 Cr | ₹2.42 Cr | ₹2.31 Cr | ₹2.38 Cr |
| Workmen and Staff Welfare Expenses | ₹0.92 Cr | ₹0.96 Cr | ₹1.39 Cr | ₹1.50 Cr | ₹1.36 Cr |
| Other Employees Cost | - | - | - | - | - |
| Other Manufacturing Expenses | ₹284 Cr | ₹255 Cr | ₹253 Cr | ₹242 Cr | ₹231 Cr |
| Sub-contracted / Out sourced services | - | - | - | - | - |
| Processing Charges | ₹93 Cr | ₹85 Cr | ₹84 Cr | ₹76 Cr | ₹79 Cr |
| Repairs and Maintenance | ₹23 Cr | ₹19 Cr | ₹19 Cr | ₹21 Cr | ₹13 Cr |
| Packing Material Consumed | ₹52 Cr | ₹49 Cr | ₹46 Cr | ₹48 Cr | ₹49 Cr |
| Other Mfg Exp | ₹116 Cr | ₹102 Cr | ₹104 Cr | ₹96 Cr | ₹89 Cr |
| General and Administration Expenses | ₹35 Cr | ₹33 Cr | ₹29 Cr | ₹29 Cr | ₹30 Cr |
| Rent , Rates & Taxes | - | - | - | - | - |
| Insurance | ₹8.95 Cr | ₹8.10 Cr | ₹7.68 Cr | ₹7.68 Cr | ₹7.88 Cr |
| Printing and stationery | ₹0.24 Cr | ₹0.22 Cr | ₹0.21 Cr | ₹0.20 Cr | ₹0.16 Cr |
| Professional and legal fees | ₹6.82 Cr | ₹7.71 Cr | ₹5.59 Cr | ₹5.66 Cr | ₹6.34 Cr |
| Traveling and conveyance | ₹3.12 Cr | ₹2.46 Cr | ₹2.55 Cr | ₹2.02 Cr | ₹1.36 Cr |
| Other Administration | ₹16 Cr | ₹15 Cr | ₹13 Cr | ₹13 Cr | ₹15 Cr |
| Selling and Distribution Expenses | ₹84 Cr | ₹74 Cr | ₹64 Cr | ₹76 Cr | ₹74 Cr |
| Advertisement & Sales Promotion | ₹2.74 Cr | ₹1.79 Cr | ₹2.33 Cr | ₹1.17 Cr | ₹1.35 Cr |
| Sales Commissions & Incentives | ₹20 Cr | ₹15 Cr | ₹13 Cr | ₹19 Cr | ₹15 Cr |
| Freight and Forwarding | ₹49 Cr | ₹48 Cr | ₹40 Cr | ₹46 Cr | ₹51 Cr |
| Handling and Clearing Charges | ₹5.69 Cr | ₹6.35 Cr | ₹5.99 Cr | ₹5.58 Cr | ₹5.49 Cr |
| Other Selling Expenses | ₹6.28 Cr | ₹2.62 Cr | ₹1.95 Cr | ₹3.80 Cr | ₹2.02 Cr |
| Miscellaneous Expenses | ₹16 Cr | ₹13 Cr | ₹11 Cr | ₹11 Cr | ₹8.95 Cr |
| Bad debts /advances written off | ₹3.66 Cr | ₹3.72 Cr | ₹1.90 Cr | ₹1.53 Cr | ₹1.69 Cr |
| Provision for doubtful debts | - | - | - | - | - |
| Losson disposal of fixed assets(net) | - | - | ₹0.18 Cr | - | - |
| Losson foreign exchange fluctuations | - | - | - | - | - |
| Losson sale of non-trade current investments | - | - | - | - | - |
| Other Miscellaneous Expenses | ₹12 Cr | ₹9.37 Cr | ₹9.40 Cr | ₹9.08 Cr | ₹7.26 Cr |
| Less: Expenses Capitalised | - | - | - | - | - |
| Total Expenditure | ₹2,254 Cr | ₹2,097 Cr | ₹2,208 Cr | ₹2,407 Cr | ₹2,156 Cr |
| Operating Profit (Excl OI) | ₹312 Cr | ₹290 Cr | ₹321 Cr | ₹309 Cr | ₹333 Cr |
| Other Income | ₹2.39 Cr | ₹16 Cr | ₹4.03 Cr | ₹2.19 Cr | ₹11 Cr |
| Interest Received | ₹1.17 Cr | ₹12 Cr | ₹2.50 Cr | ₹0.70 Cr | ₹0.72 Cr |
| Dividend Received | ₹0.00 Cr | ₹0.01 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹1.60 Cr |
| Profit on sale of Fixed Assets | - | - | - | - | - |
| Profits on sale of Investments | - | - | - | - | - |
| Provision Written Back | - | - | - | - | - |
| Foreign Exchange Gains | - | - | - | - | - |
| Others | ₹1.22 Cr | ₹3.95 Cr | ₹1.53 Cr | ₹1.49 Cr | ₹9.00 Cr |
| Operating Profit | ₹314 Cr | ₹307 Cr | ₹325 Cr | ₹312 Cr | ₹344 Cr |
| Interest | ₹36 Cr | ₹39 Cr | ₹38 Cr | ₹37 Cr | ₹24 Cr |
| InterestonDebenture / Bonds | - | - | - | - | - |
| Interest on Term Loan | ₹16 Cr | ₹15 Cr | ₹6.14 Cr | ₹9.93 Cr | ₹12 Cr |
| Intereston Fixed deposits | - | - | - | - | - |
| Bank Charges etc | ₹2.58 Cr | ₹3.17 Cr | ₹4.37 Cr | ₹3.85 Cr | ₹3.16 Cr |
| Other Interest | ₹18 Cr | ₹21 Cr | ₹27 Cr | ₹23 Cr | ₹9.05 Cr |
| PBDT | ₹278 Cr | ₹268 Cr | ₹287 Cr | ₹275 Cr | ₹320 Cr |
| Depreciation | ₹67 Cr | ₹56 Cr | ₹51 Cr | ₹50 Cr | ₹50 Cr |
| Profit Before Taxation & Exceptional Items | ₹211 Cr | ₹212 Cr | ₹236 Cr | ₹224 Cr | ₹270 Cr |
| Exceptional Income / Expenses | - | - | - | - | - |
| Profit Before Tax | ₹211 Cr | ₹212 Cr | ₹236 Cr | ₹224 Cr | ₹270 Cr |
| Provision for Tax | ₹16 Cr | ₹44 Cr | ₹64 Cr | ₹58 Cr | ₹65 Cr |
| Current Income Tax | ₹45 Cr | ₹52 Cr | ₹60 Cr | ₹59 Cr | ₹70 Cr |
| Deferred Tax | ₹2.69 Cr | ₹2.50 Cr | ₹4.37 Cr | ₹-1.04 Cr | ₹-4.78 Cr |
| Other taxes | ₹-31 Cr | ₹-11 Cr | - | - | - |
| Profit After Tax | ₹195 Cr | ₹168 Cr | ₹172 Cr | ₹166 Cr | ₹205 Cr |
| Extra items | - | - | - | - | - |
| Minority Interest | ₹-0.02 Cr | ₹0.06 Cr | ₹-0.17 Cr | ₹-0.05 Cr | ₹0.04 Cr |
| Share of Associate | - | - | - | - | - |
| Other Consolidated Items | - | - | - | - | - |
| Consolidated Net Profit | ₹195 Cr | ₹168 Cr | ₹171 Cr | ₹166 Cr | ₹205 Cr |
| Adjustments to PAT | - | - | - | - | - |
| Profit Balance B/F | ₹1,240 Cr | ₹1,155 Cr | ₹1,021 Cr | ₹879 Cr | ₹754 Cr |
| Appropriations | ₹1,435 Cr | ₹1,323 Cr | ₹1,192 Cr | ₹1,045 Cr | ₹959 Cr |
| General Reserves | ₹17 Cr | ₹16 Cr | ₹14 Cr | ₹15 Cr | ₹20 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Corporate dividend tax | - | - | - | - | - |
| Other Appropriation | - | ₹58 Cr | ₹13 Cr | ₹-0.02 Cr | ₹51 Cr |
| Equity Dividend % | ₹20.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
| Earnings Per Share | ₹21.36 | ₹18.42 | ₹18.65 | ₹17.96 | ₹22.14 |
| Adjusted EPS | ₹21.36 | ₹18.42 | ₹18.65 | ₹17.96 | ₹22.14 |
Compare Income Statement of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹3,911.7 Cr | -0.6% | 0.5% | -13.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,120.0 Cr | -3.2% | -5.4% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,390.0 Cr | 0.7% | 3.2% | 61.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,740.0 Cr | -2.8% | -3% | 32.6% | Stock Analytics | |
| CIPLA | ₹108,497.0 Cr | -2.9% | -3.3% | -10.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,925.0 Cr | -3.3% | 4.7% | -2.2% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | -0.6% |
0.5% |
-13.8% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses